Grail (GRAL) Cash from Financing Activities (2023 - 2025)

Grail's (GRAL) quarterly Cash from Financing Activities came in at $423.3 million in Q4 2025, down 54.59% on a QoQ basis from $932.3 million in Q2 2024.

Grail (GRAL) Cash from Financing Activities (2023 - 2025) Analysis & Trends

Grail (GRAL) has 3 years of Cash from Financing Activities data on file, last reported at $423.3 million in Q4 2025.

  • Quarterly Cash from Financing Activities changed N/A year-over-year to $423.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $423.3 million (down 65.98% YoY) and the FY2025 annual result came in at $423.3 million, down 65.98% from the prior year.
  • Cash from Financing Activities fell to $423.3 million in Q4 2025, from $932.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $932.3 million in Q2 2024 to a low of $74.0 million in Q4 2023.
  • A 3-year average of $365.5 million and a median of $312.0 million in 2024 frame the typical range for Cash from Financing Activities.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -1.57 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn 7.27 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -325.19 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -144.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -214.00 Mn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn 3.76 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn -129.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -317.75 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -229.00 Mn
10 Grail 3.01 Bn 2.19 Bn 19.54 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 423.32 Mn
Dec 31, 2025 423.32 Mn
Jun 30, 2024 932.30 Mn
Jun 30, 2024 932.30 Mn
Mar 31, 2024 312.00 Mn
Mar 31, 2024 312.00 Mn
Dec 31, 2023 85.99 Mn
Dec 31, 2023 85.99 Mn
Oct 1, 2023 74.01 Mn
Oct 1, 2023 74.01 Mn